Blood Flow Measurement Devices Market By Product (Ultrasonic Doppler Blood Flow Meters, Laser Doppler Blood Flow Meters, Electromagnetic Blood Flow Meters, Nuclear Magnetic Resonance (NMR) Blood Flow Meters), By Application (Cardiovascular Diseases, Gastroenterology, Diabetes, Dermatology, Tumor Monitoring & Angiogenesis, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The blood flow measurement devices market is expected to exhibit healthy growth during the forecast period from 2018 to 2026.

The global blood flow measurement devices market was worth US$ Mn in 2017 and is expected to be worth US$ Mn by 2026. Drivers responsible for the market's growth are the globally growing elderly population coupled with the rising prevalence of chronic diseases, the increasing preference of users for noninvasive devices, and mounting technological developments in blood flow meters. According to the World Health Organization (WHO), the global elderly population will increase from 841.0 million in 2013 to 962.3 million in 2017 and will surpass 2 billion by 2050. This geriatric population is more likely to develop chronic diseases (cardiovascular diseases, diabetes, chronic dermatitis, and gastritis) and other targeted diseases. As per the data provided by the WHO, worldwide, 17.7 million people die from cardiovascular diseases (CVDs), which account for 31.0% of all deaths every year. Low- and middle-income countries’ populations are highly affected by CVDs. Blood flow metres monitor the blood flow in several blood vessels and measure the cardiac output, thereby being used in the management of cardiovascular diseases.

Market Synopsis

The ultrasonic doppler blood flow metres segment led the market in 2017.

On the basis of product, the blood flow measurement devices market is categorized into ultrasonic Doppler blood flow meters, laser Doppler blood flow meters, electromagnetic blood flow meters, and nuclear magnetic resonance (NMR) blood flow meters. The ultrasonic Doppler blood flow metres segment would continue its dominance over the forecast period from 2018 to 2026 due to its broad-ranging applications to measure the velocity of blood flow at an arbitrary position within patients suffering from cardiovascular diseases and intracranial pressure monitoring. These flow metres are used in the arterial line of an extracorporeal circulation system (ECS) or heart-lung bypass procedures.

Based on application, the Others segment is forecast to register a relatively higher CAGR from 2018 to 2026.

The Others segment, which comprises intracranial pressure monitoring in neurointensive care, microvascular surgery, and coronary artery bypass grafting (CABG), would register the most significant market growth during the forecast period. This is attributed to a worldwide surge in the number of CABG procedures performed. Various blood flow metres took transit-time ultrasound flow measurement resolution to the highest level and configured microvascular flow probes during microvessel (microvascular) surgeries. The adoption of noninvasive technologies with blood flow metres for direct measurement of intracranial pressure (ICP) in neurointensive care is fostering market growth.

North America holds the dominant position due to the larger adoption of blood flow measurement devices.

Because of the presence of major market players and well-established healthcare infrastructure, the shift toward the adoption of minimally invasive procedures, and rising healthcare spending, North America held the largest market share in 2017. According to an article published in the Wall Street Journal, Americans spend more on healthcare than any other country in the world. By 2025, the U.S. will spend nearly 20.0% of its gross domestic product (GDP) on health, up from the current level of about 18.0%. Increasing drug and healthcare-related prices will drive healthcare spending in the near future.

The presence of international market participants makes market penetration challenging for new entrants.

Major players in this space are Cook Medical, Arjo, Atys Medical, Compumedics Limited, Deltex Medical Group plc, GF Health Products, Inc., Medistim, Biomedix, Inc., Moor Instruments, and ADInstruments. These key market participants are implementing organic and inorganic growth strategies such as mergers and acquisitions (M&A), new product launches, collaborations, and partnerships in order to gain a competitive advantage. Rising US Food and Drug Administration (US FDA) approvals and launches of new blood flow metres with novel advanced technologies are gaining higher momentum in the market. For instance, in June 2013, Cook Medical launched the Doppler DP-M350 Blood Flow Monitor, which detects changes in blood flow during free flap procedures.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The blood flow measurement devices market analyses current market dynamics in both qualitative and quantitative terms. The report entails all-inclusive information on the global blood flow measurement devices market by segmenting the market on the basis of product, application, and geography. This report will guide industry investors and associations, medical device industry participants, venture capitalists, suppliers and distributors of blood flow meters, medical research institutes, health insurance players, research and consulting firms, and healthcare professionals (HCPs) in decision-making and strategizing the market position.

The current report also incorporates qualitative analysis of market variables such as key market drivers, restraints, opportunities, and trends, which convey better market information about the entire market for blood flow measurement devices. Additionally, the report also comprises a graphical illustration of the competitive landscape based on their market initiatives and strategies, product portfolio, financial information, and key developments. Major market participants profiled in the study report are Cook Medical; Arjo; Atys Medical; Compumedics Limited; Deltex Medical Group plc; GF Health Products, Inc.; Medistim; Biomedix, Inc.; Moor Instruments; and ADInstruments.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the market for blood flow measurement devices, and what are the valuable opportunities for emerging players?
  • Which product contributes to the maximum market share?
  • Which product accounts for the fastest CAGR during the forecast period?
  • Which application held the major market share in 2017?
  • Which application would have the fastest segment during the forecast period?
  • What is the impact of high-cost blood flow measurement devices on the market?
  • Do low- and middle-income countries invest in blood flow measurement devices?
  • What are the market trends and dynamics in emerging markets such as Latin America, the Middle East, and Africa?

Frequently Asked Questions:

The market for Blood Flow Measurement Devices Market is expected to reach US$ XX Mn by 2026.

The Blood Flow Measurement Devices Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Cook Medical; Arjo; Atys Medical; Compumedics Limited; Deltex Medical Group plc; GF Health Products, Inc.; Medistim; Biomedix, Inc.; Moor Instruments are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Aug 2018
Category:  Medical Devices
Report ID:   59291
Report Format:   PDF
Pages:   120
Rating:    4.5 (40)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support